Purpose The purpose of this study was to compare infection control rates between implant retention and two-stage revision and assess the effectiveness of retention treatment in THA. Methods Twenty-eight debridements with implant retention (retention group) and 65 staged revisions (removal group) were retrospectively analysed and risk factors that can contribute to failure of infection control were explored. Results For the retention and removal groups, infection control rates were 50% and 78% after initial treatment, and 68% and 82% at latest follow-up, respectively. There were no significant differences in the number of additional operative procedures, total length of hospital stay, and duration of treatment between groups. Infection of revision THA, polybacterial and S. aureus infection were identified as risk factors for infection control. Conclusions Retention treatment can be considered an initial treatment option in selected cases of primary THA, with a single organism, non-S. aureus infection with 50% chance of infection control and no disadvantages in terms of additional procedure, hospital stay, and treatment duration.
Introduction
Of several treatment options for periprosthetic joint infection (PJI), irrigation and debridement (I/D) with component retention is often preferred for early postoperative or acute haematogenous infection [1] [2] [3] , and two-stage arthroplasty is considered the standard therapeutic approach [1, [4] [5] [6] [7] for chronic periprosthetic infection. In general, retention treatment reportedly has lower success rates than staged revision arthroplasty in PJI [1, 3, 7] . However, direct comparison of treatment results by different therapeutic approaches is limited due to multiple variables, including type of infection, timing of surgical treatment, study population, previous treatment histories, type and sensitivities of micro-organism, condition of implant fixation, and different definition of success or failure [8] [9] [10] [11] [12] .
For infection after total hip arthroplasty (THA), there are numerous reports of successful results of infection control. However, most of them are related to staged revision and few papers describe the retention treatment for THA infection [2, 13, 14] . Our aim therefore was to (1) compare the rate of infection control between implant retention and staged revision treatment, (2) identify factors that can contribute to infection control, and (3) outline the role of retention treatment in infected THA.
Materials and methods

Patients' characteristics
We retrospectively reviewed 104 patients with 105 infected THAs surgically treated from January 1999 to December 2007. Of these 104 patients, 12 patients were excluded; six died within less than one year follow-up from unrelated medical problems and six were lost to follow-up. This left 92 patients (93 hips) for analysis. There were 48 men and 44 women (one bilateral). The mean age at the time of initial surgical treatment was 66 (range, 39-88) years, and the mean followup was 59 (range, 20-110) months. The underlying diagnosis leading to the primary THA was osteoarthritis in 66 hips, acute femoral neck fracture in eight, developmental hip dysplasia in seven, rheumatoid arthritis in six, and avascular necrosis in six. The primary THA was performed at our institution in 49 hips and elsewhere in 44. Infection occurred after primary THA in 53 hips, while the other 40 cases were after revision THA. Nineteen hips were diagnosed and treated for infection at other hospitals then referred to our institution due to persistent infection.
Infection was diagnosed by growth of the microorganism in preoperative joint aspirates or intra-operative periprosthetic tissue specimen in conjunction with presence of an extra-articular abscess or sinus tract communicating with the joint space, purulence surrounding the prosthesis at the time of operation, or acute inflammation consistent with infection on histopathological examination [2, 10, 15] . When the culture was negative, final diagnosis was made by the surgeons' clinical decision based on clinical symptoms, signs, and laboratory data. Our cut-offs for abnormal laboratory findings were: erythrocyte sedimentation rate (ESR) greater than 25 mm/hr, C-reactive protein (CRP) greater than 8 mg/L, and joint aspirate white blood cell count (WBC) greater than 2000/μL with polymorphonuclear differential count greater than 65% [16] .
The causative organisms were isolated from preoperative synovial fluid cultures or intraoperative periprosthetic tissues in 87% of cases. Staphylococcus aureus (S. aureus) was the most common pathogen followed by coagulasenegative staphylococci and streptococci (Table 1) . Of 26 S. aureus including polybacterial cases, 11 were methicillinresistant S. aureus (MRSA) and 15 were methicillinsensitive S. aureus (MSSA).
Definition and classification
We applied the classification of McPherson et al. [17] to describe the host condition, and the infection was classified using the criteria of Tsukayama et al. [2, 17] .
We evaluated infection control rates twice: first after the initial surgical treatment and then at the latest follow-up. Treatment failure was defined as any type of additional surgical procedure for persistent or recurrent infection after initial surgery, except planned second stage reimplantation. Patients with ongoing treatment or chronic antibiotic suppression at latest follow-up were also considered as failure of infection control. Acute phase treatment was defined as surgery performed within four weeks of symptom onset in early postoperative or acute haematogenous infection, and chronic phase treatment was defined as treatment after four weeks.
Treatment course
As a treatment option, I/D with implant retention was considered the primary choice when patients presented within four weeks of symptom duration without evidence of implant loosening or chronic draining sinus. Two-stage revision arthroplasty was chosen for the primary option if patients presented after four weeks of symptoms. However, strategy of treatment was at the discretion of the surgeons based on their preoperative evaluation. Twentyeight hips underwent I/D with retention of the prosthesis with (n=19) or without (n=9) exchange of femoral head and polyethylene liner (retention group). Sixty-five hips had component removal and staged revision treatment (removal group).
In the retention group, the hip was explored, debrided, and irrigated with saline. We tried to clarify the rationale behind the surgeons' decision to changed the head and liner in some cases and not in others, but could not identify any specific and consequent strategy. In the removal group, all components and foreign materials were removed and then thorough debridement and irrigation were performed. An articulating spacer was inserted in 40 hips and nonarticulating spacer block or beads were used in 11 hips. For the spacer, 1.0 g of vancomycin and 2.4 g of tobramycin were mixed to 40 g of cement. Fourteen hips were treated by resection arthroplasty without any spacer. Organism-specific intravenous antibiotics were administrated for six weeks after surgery in both groups. Oral antibiotics were used in conjunction with intravenous antibiotic therapy in 31 (33%) hips (rifampin in 17, levofloxacin in 12, cephalexin in four, and penicillin in two). For the retention group and with an articulating spacer in the removal group, patients were allowed immediate weight bearing as tolerated and range of motion exercise. For patients with bead spacers or resection, weight bearing as tolerated was allowed four to six weeks after surgery. Reimplantation was performed when patients were judged to be free of infection, based on clinical findings, negative aspiration results after stopping antibiotics for at least two weeks, and normalisation of inflammatory markers (ESR, CRP, and WBC with differential count) with the same criteria as the diagnosis of infection. Frozen specimen analysis was used for judgment of infection by consulting with a pathologist at the time of reimplantation. The mean time period between first and second stage operations was four (range, 1-62) months.
Outcome evaluation
Patients were recommended to routinely attend in our clinic postoperatively at two weeks, one to three months, one year, and then every two to three years thereafter. Wound condition and hip function were evaluated with radiographic examination including pelvis AP, hip AP, and shoot-through lateral views. Rate of infection control, number of additional operative procedures, length of hospital stay, and treatment duration were compared between groups. In addition to potential contributing factors for infection control (Table 2) , additional variables were compared for the subgroup analysis: MRSA versus MSSA, methicillin-sensitive versus methicillin-resistant staphylococcus, modular components (femoral head and acetabular liner) exchange versus no exchange in retention treatment, and spacer insertion versus no insertion in removal treatment.
Statistics
Univariate analysis for each variable was conducted to determine candidate predictors using Fisher's exact or chisquare test with p≤0.20 as the criterion for inclusion in multivariate analysis [18] . Multivariate logistic regression was performed to identify independent predictors of failure after initial surgery and at latest follow-up. Median number of additional operations, length of stay, and treatment duration were compared by the Mann-Whitney U-test between the retention and removal groups since these variables showed skewness [19] . Two tailed values of p<0.05 were considered significant. Statistical analysis was performed using SPSS Version 17.0 (SPSS Inc, Chicago, IL).
Results
For the retention and removal groups, infection control rates were 50% and 78% after initial surgery, and 68% and 82% at latest follow-up, respectively. The overall infection control rates were 70% after initial surgery and 77% at latest follow-up. Twenty-eight failures of initial treatment (14 of 28 in the retention group, 14 of 65 in the removal group) needed subsequent additional surgical treatment after initial failure: staged revision (n=5), repeated debridement (n =6), and resection arthroplasty (n =4) in the retention group, and staged revision (n =7), repeated debridement (n=9), and resection arthroplasty (n=6) in the removal group. At latest follow-up, in both retention and removal groups, two hips were continuing treatment for uncontrolled infection and three hips were on suppressive oral antibiotics. In addition to the six hips using suppressive antibiotics, there were another 11 hips (four in the retention, seven in the removal group) with antibiotic suppression at latest follow-up. They were initially considered successful infection control after surgery, but started taking antibiotics during follow-up and were subsequently counted as failures at latest follow-up. Of those 17 hips of chronic antibiotic suppression, four were taking antibiotics for intermittent symptoms of infection without antibiotics, and 13 were taking suppressive oral antibiotics even though they did not have any symptoms of infection.
The number of additional operative procedures after initial failure ranged from zero to six in retention and zero to five in the removal group. Statistical comparison of median number of additional operative procedures, length of hospital stay (sum of hospital stay for initial surgery and additional procedures), and treatment duration (time from admission to discharge in case of infection controlled by initial surgery, or time from initial surgery to the last operation for infection control in case of initial failure) showed no significant difference between the two groups.
We identified three independent predictors for failure of infection control after initial surgery: infection of revision THA (p=0.008), acute phase treatment (less than four weeks) (p=0.04), and polybacterial infection (p=0.03) ( Table 2 ). The only risk factor associated with failure of infection control at latest follow-up was the S. aureus microorganism (odds ratio 4.2; 95% CI 1.8-11.7; p=0.006), and no other candidate variables reached statistical significance (Table 3) .
Additional subgroup analysis to identify other possible contributing factors identified no difference between MRSA and MSSA (p=0.22), methicillin-sensitive and methicillin-resistant staphylococcus (p=0.16), head/liner exchange and no exchange (p=1.0), and spacer insertion and no insertion (p=1.0).
Discussion
In our study, the rate of infection control after initial retention treatment was 50%, and this rate improved to 68% at latest evaluation by additional surgical procedures. In the previous reports of retention treatment, the rates of infection control varied both in early (38-71%) and final (14-83%) results [2, 9, 13, 14, 20, 21] . Specifically, 1-17 secondary procedures were necessary to achieve their final control rates, while we needed zero to six procedures in our series. However, direct comparison of these rates of infection control and number of additional procedures was difficult as our treatment results were based on the treatment options (retention vs. removal), while the results of other series were based on the type of infection [2] and included cases of total knee arthroplasty [9, 20, 21] . For the removal treatment, our rate of infection control was 78% after initial treatment and 82% at the latest follow-up with zero to five additional procedures. Our success rate was lower than that of other previous reports (87-95%) [2, 4, 7, 22] . We attribute our relatively low rate of final infection control to a large number of suppressive antibiotics at latest follow-up (17 of 93, 18%). In the previous reports, antibiotic suppression was used in selected cases, but they did not mention final results of those cases [4, 9] or counted their results separately [13] . One unique finding of our analysis was that acute phase treatment was identified as a predictor for initial failure. This runs counter to other previous reports which suggested shorter symptom duration had a higher probability of infection control in retention treatment [1, 14, 20] . We would not consider this result as a real risk factor, but believe this was caused by the systematic difference in treatment that our patients received in the acute versus chronic phases [2] . Most patients (28/38, 78%) received retention treatment in the acute phase and all patients received removal treatment in the chronic phase (n=55). Another explanation is that the four-week definition for the acute phase was too long, and more favourable results would be seen for treatment during earlier periods of the acute phase, such as one or two weeks after the onset of symptoms. Although three to four weeks are usually considered an acute phase in many algorithms [1] [2] [3] 17] , time criteria for early treatment in the acute phase varied considerably [1, 3, 17, 20, 21] . The other possibility is that the infection was inappropriately deemed acute when it was more indolent and chronic in nature. It is not always easy to classify infection type, when patients present with vague history of symptom onset. S. aureus is a virulent, causative organism in 20-30% of many prosthetic joint infections [9, 15, 23] and shows higher treatment failure rates [4, 9, 20] . In our study, S. aureus was also the only independent predictor for final treatment failure. Although methicillin-resistant organisms were associated with higher failure rate in other reports [8, 9, 23, 24] , we found no difference of infection control rates in our study.
Retention treatment for PJI is usually indicated for infection of short duration of symptoms, organisms susceptible to antibiotics that can be tolerated by the patient, and no prosthetic loosening [1, 13, 21] . However, attempts at infection control by retention treatment in chronic infection are still made because the patient's condition is not always adequate for repeat extensive operations [12] . In practice, many patients are not usually eager to undergo a two-stage procedure preferring to retain the prosthesis at all costs. The issue is that, when discussing treatment options with patients, there are very few data to which to refer with regard to implant retention in THA infection [2, 13, 14] . We believe that our results provide data of concurrent comparison between implant retention and removal treatment to patients. While 50-68% success rate is not ideal, it is not as low as might have been thought. Furthermore, if initial retention treatment has no disadvantages in terms of number of additional procedures, total length of hospital stay, and treatment duration, application of retention treatment in selected candidates would not be detrimental.
We recognise limitations to our study. First, as our hospital is a tertiary referral centre, many patients presented with complex prior histories related to infection or operations. This uncontrolled selection could have influenced the surgeons' choice of procedure and ultimately have affected the treatment results. Second, our study group was established over a long period of time, during which a diverse set of surgical treatments and antibiotic therapies were used without standardised strategy. Finally, we focussed on the infection control rates and did not evaluate the functional results because there was insufficient data on patients' functionality.
In summary, although the infection control rate was lower in the retention treatment group versus that of removal, initial retention could provide 50-68% chance of infection control without any disadvantage in terms of the number of additional operative procedures, length of hospital stay or duration of treatment. We suggest that retention treatment can be considered a first choice of treatment option in selected cases of infection of primary THA by a single organism other than S. aureus.
